A Multicenter Study to Obtain Data to Assist in Radiation Dosimetry Calculations From Subjects Enrolled in Human Studies Employing 18F-AV-1451
Phase of Trial: Phase I
Latest Information Update: 29 Jan 2016
At a glance
- Drugs Flortaucipir F 18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- Sponsors Avid Radiopharmaceuticals
- 22 Jan 2016 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 04 Feb 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 16 Jan 2015 New trial record